Design in Nature

The article by Steve Bunk in the April 13 issue of The Scientist (12[8]:4, April 13, 1998) contained an astonishing range of new developments in the Darwinian counter-culture, so many and so well focused that I'm curious about his sources and the circles he apparently travels in. While I try to keep abreast of all significant books and articles on either side of the evolution issue, this presentation makes me suspect there must be some forum or venue besides talk.origins in which these concepts

Written byRobert Slate
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The article by Steve Bunk in the April 13 issue of The Scientist (12[8]:4, April 13, 1998) contained an astonishing range of new developments in the Darwinian counter-culture, so many and so well focused that I'm curious about his sources and the circles he apparently travels in. While I try to keep abreast of all significant books and articles on either side of the evolution issue, this presentation makes me suspect there must be some forum or venue besides talk.origins in which these concepts are exchanged.

The idea of enlisting shamans or narcotic drugs to penetrate the mysteries of biological complexity is particularly intriguing. Although certainly a long shot, if any of these efforts succeed, the results will be earth-shaking and will rattle the halls of academia.

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies